Paid Clinical Trials in Norfolk, VA
As of September 2026, 283 paid clinical trials are recruiting in Norfolk, Virginia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Norfolk offers studies at sites including Virginia Oncology Associates for conditions such as Breast Cancer, Heart Failure, Duchenne Muscular Dystrophy, Multiple Myeloma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Norfolk
Trials by drug in Norfolk
Filter results
Newly added in Norfolk
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
261 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Top Research Study Locations in Norfolk
Researchers run research studies in Norfolk, VA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Virginia Oncology Associates | Breast Cancer, Multiple Myeloma, Colorectal Cancer | 39 |
| Children's Hospital of The King's Daughters | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Duchenne Muscular Dystrophy | 38 |
| Sentara Norfolk General Hospital | Aortic Valve Stenosis, Malignant Solid Neoplasm, Mitral Regurgitation | 29 |
| Virginia Oncology Associates (VOA) | Breast Neoplasms, Breast Cancer, Bladder Cancer | 6 |
| Old Dominion University | Exercise, Cardiovascular (CV) Risk, Cleft Lip Palate | 5 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 4 |
| Eastern Virginia Medical School | Alzheimer Disease, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Dementia | 4 |
| Sentara Health | Acute Kidney Injury, Blood Pressure, Coronary Artery Disease | 4 |
| Sentara Health Research Center | Abdominal Aortic Aneurysm (AAA), Heart Failure, Obesity | 4 |
| Virginia Eye Consultants | Corneal Scar, Neurotrophic Keratopathy, Non-infectious Anterior Uveitis | 4 |
| Virginia Pediatric Eye Center | Amblyopia, Myopia | 4 |
| Sentara Heart Hospital | AAA - Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm, Chronic Thromboembolic Pulmonary Hypertension | 3 |
| Sentara Cardiovascular Research Institute | Aortic Stenosis, Aortic Stenosis, Severe, Transthyretin Amyloid Cardiomyopathy (ATTR CM) | 3 |
| Tidewater Physicians for Women | Contraception, Healthy, RSV Infection | 3 |
| Virginia Clinical Research | Alopecia, Areata Alopecia, Hair Diseases | 3 |
| AMR Clinical - Norfolk | Acute Migraine, Migraine | 2 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Ascendis Investigational Site | Growth Hormone Deficiency | 2 |
| Children's Specialty Group | Crohn Disease, Narcolepsy Type 1 | 2 |
| Children's Specialty Group (CSG) | Chronic Migraine in Children, Episodic Migraine | 2 |
| Childrens Hospital of the Kings Daughter Norfolk | Muscular Atrophy, Spinal, Spinal Muscular Atrophy | 2 |
| Eastern Virginia Medical School - Old Dominion University | Gestational Diabetes Mellitus, Gestational Hypertension, Hypertensive Disorders of Pregnancy | 2 |
| GSK Investigational Site | Neoplasms, Non-alcoholic Fatty Liver Disease | 2 |
| Macon & Joan Brock Virginia Health Sciences at Old Dominion University | Hemolytic Disease of the Fetus and Newborn, Preeclampsia (PE) | 2 |
| Sentara | In-stent Thrombosis, Pulmonary Embolism | 2 |
Active & Upcoming Studies in Norfolk (2026)
Recruiting trials in Norfolk grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (84 active studies)
- Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia · Phase 3 · Children's Oncology Group
- Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · Phase 2, Phase 3 · Pfizer
Cardiovascular (25 active studies)
- A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. · P+F Products + Features USA Inc.
- A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension · Cosmos Rx, Inc
Diabetes & metabolic (15 active studies)
- A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight · Phase 3 · AstraZeneca
- A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
Neurology & pain (15 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Pediatric (5 active studies)
- Early Intervention in Infants With Unrepaired Cleft Palate: Language, Palatal Function, and Articulation. · Old Dominion University
- A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine · Phase 3 · H. Lundbeck A/S
Eye & vision (3 active studies)
- A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD · Skyline Therapeutics
- A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) · Phase 2, Phase 3 · Janssen Research & Development, LLC
Vaccines (1 active study)
HIV / STI (1 active study)
- PrEPwise Pilot Among Black Women in Eastern Virginia · Boston University
Common conditions studied in Norfolk
- Breast Cancer (8 active studies)
- Heart Failure (8 active studies)
- Duchenne Muscular Dystrophy (5 active studies)
- Multiple Myeloma (5 active studies)
- Acute Myeloid Leukemia (4 active studies)
- Breast Neoplasms (4 active studies)
Leading research sponsors in Norfolk
- AstraZeneca
- Children's Oncology Group
- National Cancer Institute (NCI)
- Eli Lilly and Company
- Merck Sharp & Dohme LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Norfolk?
There are approximately 283 recruiting clinical trials in Norfolk, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Norfolk pay participants?
Most recruiting trials in Norfolk compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Norfolk?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Norfolk?
The most common conditions under active study in Norfolk include Breast Cancer (8), Heart Failure (8), Duchenne Muscular Dystrophy (5), Multiple Myeloma (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Norfolk?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Norfolk on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Norfolk?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Norfolk?
Recruiting research sites in Norfolk include Virginia Oncology Associates, Children's Hospital of The King's Daughters, Sentara Norfolk General Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Norfolk right now?
The largest active categories in Norfolk are Cancer & tumors (84), Cardiovascular (25), Diabetes & metabolic (15). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.